Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?

To: Henry Niman who wrote (15209)	2/17/1998 6:06:00 PM
From: Hippieslayer	Read Replies (2) \| Respond to of 32384

Here's some interesting news regarding a possible new way to fight cancer eurekalert.org:80/releases/cancsweet-tooth.html and, as you can observe from the 2 year chart of ligand, the trading range has roughly been between 12 and 16 with a couple dips below 12 and a couple breakouts above 16. Hence, until we get some real forward momentum with positive clinical news, new brokerage houses getting on the buy bandwagon, FDA approval, and earnings that are in the black (or any combo of the above), lgnd will most probably stay between the 12-16 range. Let's not forget that if there is a market meltdown (due to war, etc) lgnd will get hit hard. quote.yahoo.com